Mizuho Trust & Banking’s Teva Pharmaceuticals TEVA Stock Holding History

Mizuho Trust & Banking’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-196,300	Closed	-$9.03M	–	586
2016 Q3	$9.03M	Buy	196,300 +20,700	+12%	+$1.08M	0.03%	560
2016 Q2	$8.82M	Buy	175,600 +78,200	+80%	+$4.16M	0.03%	563
2016 Q1	$5.21M	Buy	+97,400	New	+$5.71M	0.02%	625
2015 Q4	–	Sell	-111,400	Closed	-$6.29M	–	838
2015 Q3	$6.29M	Sell	111,400 -11,550	-9%	-$749K	0.02%	601
2015 Q2	$7.27M	Sell	122,950 -11,350	-8%	-$700K	0.02%	602
2015 Q1	$8.37M	Hold	134,300	–	–	0.03%	578
2014 Q4	$7.72M	Hold	134,300	–	–	0.03%	585
2014 Q3	$7.19M	Hold	134,300	–	–	0.03%	573
2014 Q2	$7.04M	Hold	134,300	–	–	0.03%	606
2014 Q1	$7.1M	Buy	+134,300	New	+$6.21M	0.03%	590

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Mizuho Trust & Banking's TEVA Position: Q4 2016 in Review

Mizuho Trust & Banking sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 196,300 shares — an estimated $9.03M sold.

Mizuho Trust & Banking first reported a position in TEVA in Q1 2014 and held it in 10 quarters. The position peaked at $9.03M in Q3 2016. 739 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Mizuho Trust & Banking reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Mizuho Trust & Banking sold 196,300 Teva Pharmaceuticals shares in Q4 2016, an estimated $9.03M.
Mizuho Trust & Banking first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 10 quarters.
Mizuho Trust & Banking's Teva Pharmaceuticals position peaked at $9.03M in Q3 2016.
739 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Mizuho Trust & Banking's 13F filing for Q4 2016, filed 14 Feb 2017.